eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Imodium, Lomotil, Warfarin Sodium for a Male patient aged 49

This is a personalized study for a 49 year old male patient. The study is created by eHealthMe based on reports of 69 people who take the same drugs and have drug interactionsfrom FDA.

On Nov, 13, 2014: 69 people who reported to have interactions when taking Imodium, Lomotil, Warfarin Sodium are studied

Trend of Imodium, Lomotil, Warfarin Sodium's drug interactions, side effects, and effectiveness reports (665926)

Information of the patient in this study:

Age: 49

Gender: male

Drugs taking:
- Imodium
- Lomotil
- Warfarin Sodium

Drug interactions have: Enteritis

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 49 (±5):

InteractionNumber of reports
Enteritis (inflammation of the small intestine)2 (100.00%)

Most common interactions experienced by males aged 49 (±5) in the use of Imodium, Lomotil, Warfarin Sodium:

InteractionNumber of reports
Enteritis (inflammation of the small intestine)2
Colitis (inflammation of colon)2

Most common interactions experienced by males aged 49 (±5) in long term use of Imodium, Lomotil, Warfarin Sodium:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Enteritis (inflammation of the small intestine)2 (2.90%)

Most common interactions experienced by people in the use of Imodium, Lomotil, Warfarin Sodium:

InteractionNumber of reports
Diarrhoea57
Nausea (feeling of having an urge to vomit)36
Anxiety34
Vomiting34
Anaemia (lack of blood)33
Dehydration (dryness resulting from the removal of water)30
Pain27
Hypertension (high blood pressure)26
Fatigue (feeling of tiredness)26
Electrolyte Imbalance26

Most common interactions experienced by people in long term use of Imodium, Lomotil, Warfarin Sodium:

InteractionNumber of reports
International Normalised Ratio Increased2
Haematemesis (vomiting of blood)2
Duodenal Ulcer (stomach ulcer)2
Diarrhoea2
Duodenal Ulcer Haemorrhage (bleeding duodenal ulcer)2
Haemoglobin Decreased2
Nausea (feeling of having an urge to vomit)2
Vomiting2
Weight Abnormal2

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.